| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.02B | 30.40B | 28.40B | 25.72B | 22.06B | 20.90B |
| Gross Profit | 20.66B | 21.59B | 20.19B | 17.83B | 12.87B | 11.69B |
| EBITDA | 3.94B | 4.60B | 3.73B | 2.88B | 2.13B | 2.31B |
| Net Income | 2.10B | 2.71B | 1.95B | 1.41B | 722.79M | 474.10M |
Balance Sheet | ||||||
| Total Assets | 43.68B | 43.90B | 43.48B | 43.00B | 42.66B | 39.06B |
| Cash, Cash Equivalents and Short-Term Investments | 4.14B | 3.97B | 4.10B | 3.59B | 5.22B | 3.45B |
| Total Debt | 14.80B | 13.42B | 15.20B | 15.28B | 17.79B | 17.32B |
| Total Liabilities | 27.25B | 25.57B | 27.30B | 28.34B | 29.14B | 25.38B |
| Stockholders Equity | 16.42B | 18.31B | 16.17B | 14.64B | 13.50B | 13.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.74B | 2.14B | 2.38B | 243.90M | 1.64B |
| Operating Cash Flow | 0.00 | 4.76B | 4.14B | 3.61B | 1.42B | 2.29B |
| Investing Cash Flow | 0.00 | -1.64B | -2.01B | -1.28B | 1.26B | -1.71B |
| Financing Cash Flow | 0.00 | -3.26B | -1.62B | -3.96B | -908.99M | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥52.10B | 3.26 | ― | ― | 8.21% | 26.07% | |
69 Neutral | ¥32.35B | 35.22 | ― | 1.35% | 12.51% | 11.23% | |
68 Neutral | ¥39.05B | 14.56 | ― | 1.42% | 7.06% | 38.85% | |
66 Neutral | ¥20.57B | 7.10 | ― | 0.76% | 18.01% | -2.49% | |
64 Neutral | ¥376.53B | 17.60 | 10.65% | 1.64% | 5.49% | 3.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥6.39B | 15.09 | ― | 2.41% | 0.03% | -0.59% |